Vortex “As a clinician, I am excited about accessing the cancer biology of patient’s through CTCs. Vortex’s technology provides the best source of CTCs to aid in the diagnostic and treatment decisions we face every day.” – Dr. Jonathan Goldman, MD, Director of Clinical Trials in Thoracic Oncology, Associate Director of Drug Development at UCLA “Improving CTCs recovery along with high cellular purity while maintaining viability have tremendous value for translational research and clinical diagnostic applications. The VTX-1 holds the potential to revolutionize blood-based diagnostics.” - Pr. Massimo Cristofanilli, MD, FACP, Professor of Medicine, Associate Director of Translational Research and Precision Medicine, Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine Wanda J. Cribbs, Lead Gartner Analyst Population Health & Analytics says: "Wanda's recent HRS press release really stands out. Delivering those results and having a client publicly share credit with their vendor is rare and says a lot. We at Gartner will have our eyes on Wanda in 2018"

Scientific Advisers

Dino Di Carlo, PhD

Jonathan Goldman, M.D

Massimo Cristofanilli, M.D

Stanley Frankel, M.D

Timothy Block, PhD

Anand Mehta, DPhil

David Chernoff, MD

Scott Friedman, MD

Douglas Dieterich, MD

Dr. Janki Shah

Dr. Costanzo DiPerna

Jeff Moreland

Dr. Clyde Wesp

Majid Sarrafzadeh Ph.D

Stuart Elborn

Scott Sagel

James Chalmers

Patrick Flume

Penny Agent

Marcus Mall

Mona Bafadhel

Darron R. Brown, M.D.

Robert P. Edwards, M.D.

Mark Einstein, M.D.

Leaf Huang, Ph.D.

Samir N. Khleif, M.D.

Lisa Rohan, Ph.D.

Jerold G. Woodward, Ph.D.

Scientific Advisers - NetScientific
No announcement available or all announcement expired.